Oscar Health Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Oscar Health stock has a consensus rating of "Hold" and an average price target of $34.6. The average 1-year stock price forecast is 7.69% higher than the current stock price, while the lowest is $26 (-19.08%) and the highest is $49 (+52.51%).

Price Target: $34.6 (+7.69%)

Analyst Consensus: Hold

Price Target

Chart

Target	Low	Average	Median	High
Price	$26	$34.6	$33.5	$49
Change	-19.08%	+7.69%	+4.26%	+52.51%

Analyst Ratings

The average analyst rating for Oscar Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Jul '26	Aug '26	Sep '26
Strong Buy	0	0	0	0	0	0
Buy	2	2	3	3	3	3
Hold	6	7	7	7	7	7
Sell	1	1	1	1	1	1
Strong Sell	1	1	0	0	0	0
Total	10	11	11	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Parker Snure Raymond James	Raymond James	Buy Maintains $34 → $42	Buy	Maintains	$34 → $42	+30.72%	Sep 18, 2026
Jessica Tassan Piper Sandler	Piper Sandler	Buy Reiterates $36 → $48	Buy	Reiterates	$36 → $48	+49.39%	Sep 17, 2026
David Windley Jefferies	Jefferies	Hold Maintains $31	Hold	Maintains	$31	-3.52%	Sep 17, 2026
Michael Ha Robert W. Baird	Robert W. Baird	Hold Maintains $27 → $33	Hold	Maintains	$27 → $33	+2.71%	Sep 17, 2026
Scott Fidel Goldman Sachs	Goldman Sachs	Hold Maintains $30 → $34	Hold	Maintains	$30 → $34	+5.82%	Sep 17, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

18.73B

from 11.70B

60.08%

from 11.70B

Revenue Next Year

20.79B

from 18.73B

11.01%

from 18.73B

EPS This Year

1.91

from -1.69

EPS Next Year

2.17

from 1.91

13.20%

from 1.91

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.89B	3.96B	5.86B	9.18B	11.70B	18.73B
Revenue Growth	384.43%	109.27%	47.92%	56.54%	27.50%	60.08%
Net Income	-572.61M	-606.28M	-270.73M	25.43M	-443.15M	654.97M
EPS	-	-	-	-	-1.69	1.91
Forward PE	-	-	-	28.43	278.94	16.80
Free Cash Flow	-	-	-	-	1.06B	3.19B
No. Analysts	-	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	18.9B
Avg	18.7B
Low	18.4B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	61.1%
Avg	60.1%
Low	57.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	2.12
Avg	1.91
Low	1.75

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-